WRKY23 Antibody

What is WRKY23 and why is it important for plant research?

WRKY23 belongs to a superfamily of transcription factors (TFs) that play multiple roles in plants' growth, development, and environmental stress response. The protein contains a characteristic WRKYGQK motif that provides high binding preference to W-box elements (TTGACT/C) in target gene promoters . WRKY23 is particularly unique among WRKY family members because of its responsiveness to auxin signaling pathways, while most other WRKY genes do not show this response pattern . Its importance stems from its involvement in crucial developmental processes including root development, embryogenesis, and plant defense mechanisms against pathogens such as nematodes .

What are the structural characteristics of WRKY23 protein that antibodies typically target?

WRKY23 contains a highly conserved WRKY domain with a zinc-finger motif, classifying it as a member of the WRKY IIc subfamily . Antibodies against WRKY23 are typically designed to recognize either the conserved WRKY domain or unique regions that differentiate it from other WRKY family proteins. Sequence alignment analyses have revealed that WRKY23 shares varying degrees of sequence identity with other WRKY proteins: 99.6% with GmWRKY3, 93.1% with GmWRKY54, 91.2% with VuWRKY23, and 55.7% with AtWRKY23 . When selecting or developing antibodies, researchers should consider these homology relationships to ensure specificity toward WRKY23 rather than cross-reactivity with related proteins.

How can I validate WRKY23 antibody specificity in plant tissues?

Validating antibody specificity is crucial for reliable experimental results. A comprehensive validation approach includes:

• Western blot analysis comparing wild-type plants to wrky23 knockout/knockdown mutants (such as the CRISPR/Cas9-generated wrky23 allelic mutants described in the literature)

• Immunoprecipitation followed by mass spectrometry to confirm target identity

• Testing with recombinant WRKY23 protein as a positive control

• Preabsorption tests with the immunizing peptide to confirm specificity

• Comparing results with tagged WRKY23 protein detection using anti-tag antibodies (e.g., in transgenic ProWRKY23:gWRKY23-GFP lines, where GFP antibodies can validate WRKY23 antibody performance)

What are the most effective methods for detecting WRKY23 protein expression during callus formation and regeneration?

For monitoring WRKY23 protein expression during callus formation and regeneration, researchers have successfully employed multiple complementary techniques:

• Immunoblotting with anti-WRKY23 antibodies: Total proteins should be extracted from plant tissues using a comprehensive Plant Total Protein Extraction Kit. Proteins can be separated by 12% SDS-PAGE and transferred to nitrocellulose membranes. Primary anti-WRKY23 antibody (typically used at 1:5000 dilution) followed by horseradish peroxidase-labeled secondary antibody (1:10000) allows detection with enhanced chemiluminescence (ECL) reagents .

• Fluorescent protein fusion approaches: The literature describes transgenic ProWRKY23:gWRKY23-GFP lines where WRKY23 accumulation was directly visualized in nuclei of pericycle cells and callus cells forming from roots, hypocotyls, and cotyledons after incubation on callus-inducing medium (CIM) . This approach permits both protein quantification via immunoblotting with anti-GFP antibodies and subcellular localization studies.

• Immunohistochemistry: Fixed and sectioned plant tissues can be probed with anti-WRKY23 antibodies to map expression patterns at the tissue and cellular levels.

Research has shown that WRKY23 abundance markedly increases in callus cells forming from various plant tissues after incubation on CIM, with the protein localizing predominantly to cell nuclei .

How can WRKY23 antibodies be utilized in ChIP-qPCR experiments to identify downstream targets?

Chromatin immunoprecipitation followed by quantitative PCR (ChIP-qPCR) with WRKY23 antibodies is a powerful approach to identify direct transcriptional targets. Based on published methodologies:

• Sample preparation: Use transgenic plants (e.g., wrky23-3 ProWRKY23:gWRKY23-GFP) incubated in liquid CIM or treated with auxin

• Crosslinking: Treat tissue samples with 1% formaldehyde to crosslink protein-DNA complexes

• Chromatin isolation and fragmentation: Isolate nuclei and sonicate to generate DNA fragments of 200-500 bp

• Immunoprecipitation: Incubate chromatin with anti-WRKY23 antibodies (or anti-GFP antibodies for tagged versions) and protein A/G beads

• Washing and elution: Remove non-specific binding through stringent washing followed by complex elution

• Reverse crosslinking and DNA purification: Reverse formaldehyde crosslinks and purify DNA

• qPCR analysis: Design primers targeting potential binding sites in promoter regions, particularly focusing on W-box elements (TTGACT/C)

Using this approach, research has demonstrated that WRKY23 binds directly to the promoter regions of PLT3 and PLT7 genes, but not to PLT1, PLT2, and WOX5 promoters . The binding specificity correlates with the presence of W-box elements in these promoters, consistent with WRKY23's role as a transcriptional activator.

What protocols have been optimized for immunofluorescence localization of WRKY23 in different plant tissues?

Optimized immunofluorescence protocols for WRKY23 localization in plant tissues typically include:

• Tissue fixation: Fix freshly harvested tissues in 4% paraformaldehyde or use freeze substitution techniques to preserve protein antigenicity and cellular architecture

• Embedding and sectioning: Embed in paraffin or resin and section to 5-10 μm thickness

• Antigen retrieval: Perform citrate buffer-based antigen retrieval to expose epitopes

• Blocking: Block with 3-5% BSA or normal serum to reduce non-specific binding

• Primary antibody incubation: Apply anti-WRKY23 antibodies (1:100-1:500 dilution) and incubate overnight at 4°C

• Secondary antibody application: Use fluorescently labeled secondary antibodies (1:200-1:1000)

• Counterstaining: Apply DAPI (1 μg/mL) to visualize nuclei

• Confocal microscopy: Image using appropriate excitation/emission settings

Alternative approaches include utilizing transgenic lines expressing fluorescently tagged WRKY23, such as ProWRKY23:gWRKY23-GFP, which has been successfully used to visualize WRKY23 accumulation in the nuclei of pericycle or pericycle-like cells and callus cells forming from roots, hypocotyls, and cotyledons .

How can WRKY23 antibodies be used to investigate protein-protein interactions in auxin signaling pathways?

WRKY23 antibodies can facilitate investigation of protein-protein interactions in auxin signaling pathways through several approaches:

• Co-immunoprecipitation (Co-IP): Anti-WRKY23 antibodies can pull down WRKY23 protein complexes from plant cell extracts. The precipitated complexes can then be analyzed by mass spectrometry or immunoblotting to identify interacting partners. This approach could reveal interactions with ARF7 and ARF19, which are implicated in regulating WRKY23 expression .

• Proximity-dependent biotin identification (BioID): By fusing WRKY23 to a biotin ligase and using anti-WRKY23 antibodies for verification, researchers can identify proteins that are in close proximity to WRKY23 in living cells.

• Bimolecular fluorescence complementation (BiFC): Combined with antibody validation, this approach can visualize protein-protein interactions in planta.

• Chromatin interaction analysis: Using antibodies against both WRKY23 and potential interacting partners (such as ARF transcription factors) in sequential ChIP experiments can determine if these proteins co-occupy the same genomic regions.

Research has shown that WRKY23 acts downstream of ARF7 and ARF19 in auxin signaling pathways but is not directly regulated by LBD proteins like LBD16 and LBD29 . The immunoprecipitation approaches described above could further elucidate the molecular mechanisms underlying these regulatory relationships and identify additional interaction partners.

What are the challenges in detecting WRKY23 post-translational modifications using antibody-based techniques?

Detecting post-translational modifications (PTMs) of WRKY23 presents several challenges:

• Low abundance of modified forms: PTMs often occur on a small fraction of the total protein pool, making detection difficult without enrichment strategies

• Modification-specific antibodies: Generating antibodies specific to phosphorylated, ubiquitinated, or otherwise modified WRKY23 requires precise knowledge of modification sites

• Transient nature of modifications: Many PTMs are rapidly added and removed in response to stimuli, necessitating careful timing of sample collection

• Multiple modification sites: WRKY transcription factors can be modified at multiple residues, creating a complex pattern of modifications

• Cross-reactivity concerns: Modified-specific antibodies may cross-react with similar motifs in other proteins

Addressing these challenges requires:

• Phosphoproteomic analysis to identify precise modification sites

• Generation of modification-specific antibodies

• Enrichment strategies like phosphopeptide enrichment or ubiquitin remnant profiling

• Use of kinase or phosphatase inhibitors to stabilize modifications

• Validation with recombinant proteins bearing site-specific modifications

Understanding WRKY23 post-translational modifications could reveal important regulatory mechanisms, particularly in the context of auxin signaling and stress responses where rapid modulation of transcription factor activity is often required.

How can WRKY23 antibodies be applied in single-cell protein analysis of plant stem cell niches?

Single-cell protein analysis of WRKY23 in plant stem cell niches represents an advanced application combining antibody techniques with emerging single-cell technologies:

• Single-cell immunohistochemistry: Using highly specific WRKY23 antibodies with advanced imaging techniques such as super-resolution microscopy to visualize protein expression at the single-cell level in intact tissues

• Flow cytometry with fluorescently labeled antibodies: Protoplasting stem cell regions followed by fixation, permeabilization, and staining with fluorescently-labeled anti-WRKY23 antibodies to quantify expression levels in individual cells

• Mass cytometry (CyTOF): Using metal-conjugated anti-WRKY23 antibodies to simultaneously detect multiple proteins in single cells with high sensitivity

• Microfluidic antibody capture techniques: Capturing individual protoplasts in microfluidic devices followed by on-chip immunoassays for WRKY23 detection

• In situ proximity ligation assay (PLA): Detecting WRKY23 interactions with other proteins at single-molecule resolution within individual cells

Given WRKY23's role in stem cell specification in Arabidopsis embryos , these approaches could provide unprecedented insights into how its expression varies across different cells within stem cell niches and how this heterogeneity contributes to development and differentiation processes. Combining these antibody-based techniques with single-cell transcriptomics could further elucidate the relationship between WRKY23 expression and downstream transcriptional networks at the single-cell level.

What are the most common issues when using WRKY23 antibodies in plant protein extracts and how can they be resolved?

Researchers frequently encounter several challenges when working with WRKY23 antibodies in plant protein extracts:

For optimal WRKY23 protein extraction, research indicates success with specialized Plant Total Protein Extraction Kits followed by separation on 12% SDS-PAGE gels . Adding nuclear enrichment steps can significantly improve detection of this nuclear-localized transcription factor.

How can I optimize immunoprecipitation protocols specifically for WRKY23 complex isolation?

Optimizing immunoprecipitation (IP) protocols for WRKY23 complexes requires consideration of several factors:

• Extraction buffer composition:

  • Use buffers containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 0.1% Triton X-100

  • Include protease inhibitor cocktail and phosphatase inhibitors

  • Add 1-2% NP-40 or 0.5% sodium deoxycholate to improve nuclear protein solubilization

  • Consider including 10-20 mM N-ethylmaleimide to preserve ubiquitination

• Crosslinking optimization:

  • For transient interactions, use membrane-permeable crosslinkers like DSP (dithiobis(succinimidyl propionate))

  • For DNA-bound complexes, use 1% formaldehyde for 10-15 minutes

• Antibody coupling strategies:

  • Direct coupling to protein A/G beads may improve background

  • Pre-clearing lysates with beads alone removes non-specific binding proteins

  • Consider using tagged versions (like WRKY23-GFP) with commercial anti-tag antibodies

• Washing conditions:

  • Incremental increase in salt concentration (150 mM to 300 mM NaCl)

  • Include detergents at low concentrations (0.1% Triton X-100 or NP-40)

  • Test multiple wash buffers with increasing stringency

• Elution methods:

  • Gentle elution with peptide competition if the epitope is known

  • Low pH glycine buffer (pH 2.5-3.0) followed by immediate neutralization

  • Sample buffer at 95°C for complete dissociation

From published protocols, successful WRKY23 complex isolation has been achieved in transgenic Arabidopsis lines, enabling the identification of its interaction with promoter regions of target genes like PLT3 and PLT7 .

What are the best practices for preserving WRKY23 antigenicity during tissue fixation for immunohistochemistry?

Preserving WRKY23 antigenicity during tissue fixation requires balancing structural preservation with epitope accessibility:

• Optimal fixative selection:

  • 4% paraformaldehyde in PBS (pH 7.2-7.4) for 2-4 hours is generally suitable

  • Avoid over-fixation which can mask epitopes

  • Consider adding 0.1-0.5% glutaraldehyde only if structural preservation is critical

• Fixation conditions:

  • Perform fixation at 4°C to reduce protein degradation

  • Use vacuum infiltration for 15-20 minutes to ensure fixative penetration

  • Limit fixation time to the minimum needed (often 2-4 hours is sufficient)

• Post-fixation processing:

  • Wash thoroughly in PBS to remove excess fixative

  • Use sucrose gradients (10-30%) for cryoprotection if freezing

  • For paraffin embedding, minimize high-temperature exposure during processing

• Antigen retrieval methods:

  • Heat-induced epitope retrieval (HIER) with citrate buffer (pH 6.0)

  • Enzymatic retrieval with proteinase K (1-5 μg/mL) for brief periods

  • Experiment with different retrieval methods as optimal conditions may vary

• Alternative approaches:

  • Freeze substitution can preserve both structure and antigenicity

  • Cryosectioning unfixed tissue followed by gentle fixation of sections

  • Progressive lowering of temperature (PLT) embedding

Research on plant transcription factors suggests that the nuclear localization of WRKY23 makes appropriate fixation crucial, as demonstrated in studies visualizing WRKY23-GFP in the nuclei of various plant cell types .

How should researchers interpret contradictory results between WRKY23 antibody detection and transcript expression data?

Discrepancies between WRKY23 protein levels (detected by antibodies) and transcript levels are common and biologically meaningful. When interpreting such contradictions:

• Consider post-transcriptional regulation:

  • WRKY transcription factors can be subject to microRNA targeting

  • mRNA stability may vary under different conditions

  • Translation efficiency can be regulated by RNA-binding proteins

• Evaluate post-translational regulation:

  • Protein stability differences (research has shown dynamic regulation of WRKY23 protein levels during callus induction while transcript patterns may differ)

  • Compartmentalization (nuclear import/export) affecting antibody accessibility

  • Masking of epitopes by protein interactions or modifications

• Technical considerations:

  • Different sensitivities of detection methods (qPCR vs. immunoblotting)

  • Temporal delays between transcription and translation

  • Protein extraction efficiency variations

• Biological implications:

  • Temporal uncoupling of transcription and translation as regulatory mechanisms

  • Condition-specific protein stabilization or degradation

  • Different half-lives of mRNA vs. protein

What novel research questions about WRKY23 function can be addressed using cutting-edge antibody-based technologies?

Cutting-edge antibody-based technologies enable addressing several novel research questions about WRKY23:

• Spatial and temporal dynamics using live-cell antibody imaging:

  • How does WRKY23 nuclear localization change in response to auxin gradients?

  • What is the real-time kinetics of WRKY23 recruitment to chromatin?

  • How do environmental stresses alter WRKY23 subcellular distribution?

• Protein complex composition using proximity labeling with antibody validation:

  • What is the complete interactome of WRKY23 in different developmental contexts?

  • How do WRKY23 protein complexes differ between root and shoot tissues?

  • Do stress conditions alter WRKY23 interaction partners?

• Chromatin organization using CUT&RUN or CUT&Tag with WRKY23 antibodies:

  • What is the complete cistrome of WRKY23 across different tissues and conditions?

  • How does WRKY23 binding relate to chromatin accessibility changes?

  • Are there pioneer factor activities of WRKY23 in developmental transitions?

• Post-translational modification patterns using modification-specific antibodies:

  • What is the phosphorylation code of WRKY23 under different conditions?

  • How does ubiquitination regulate WRKY23 stability during development?

  • Are there novel modifications like SUMOylation affecting WRKY23 function?

• Conformational dynamics using conformation-sensitive antibodies:

  • Does WRKY23 undergo structural changes upon DNA binding?

  • How do plant hormones influence WRKY23 protein conformation?

Given WRKY23's roles in auxin signaling, plant defense, and development , these approaches could reveal how this transcription factor integrates multiple signaling inputs to coordinate appropriate transcriptional responses.

How can researchers use WRKY23 antibodies to investigate its evolutionary conservation across plant species?

Investigating evolutionary conservation of WRKY23 across plant species using antibodies requires strategic approaches:

• Cross-species reactivity testing:

  • Test existing WRKY23 antibodies against protein extracts from diverse plant species

  • Create a reactivity profile based on sequence homology predictions

  • Align sequences to identify conserved epitopes across species

• Epitope mapping for conservation analysis:

  • Determine the specific epitopes recognized by various WRKY23 antibodies

  • Compare epitope conservation across evolutionary diverse plant species

  • Generate epitope-specific antibodies targeting highly conserved regions

• Comparative immunoprecipitation studies:

  • Perform IP-MS studies in multiple species using the same antibodies

  • Compare WRKY23 interactomes across evolutionary distance

  • Identify conserved vs. species-specific interaction partners

• Functional conservation assays with antibody validation:

  • Use antibodies to assess WRKY23 binding to conserved target promoters across species

  • Compare subcellular localization patterns in different plant lineages

  • Evaluate conservation of post-translational modifications

• Data integration:

  • Correlate antibody cross-reactivity with sequence divergence metrics

  • Map conservation data onto three-dimensional structural models

  • Create evolutionary distance trees based on epitope conservation

Amino acid sequence alignment studies have shown that WRKY23 shares varying degrees of identity with related proteins across species: 99.6% with GmWRKY3 (soybean), 93.1% with GmWRKY54, 91.2% with VuWRKY23 (cowpea), 74.8% with AhWRKY23, 67.9% with MtWRKY23 (Medicago), 63.7% with JrWRKY23, and 55.7% with AtWRKY23 (Arabidopsis) . This sequence conservation data provides a foundation for antibody-based evolutionary studies.

How might antibody engineering advance WRKY23 research beyond current technological limitations?

Antibody engineering presents exciting opportunities to overcome current limitations in WRKY23 research:

• Single-domain antibodies (nanobodies):

  • Development of plant-optimized nanobodies against WRKY23 for in vivo imaging

  • Expression of anti-WRKY23 nanobodies fused to degradation tags for targeted protein degradation

  • Intrabodies to track WRKY23 in living plant cells without fluorescent protein fusions

• Antibody fragments with enhanced properties:

  • Smaller Fab or scFv fragments with improved tissue penetration

  • Recombinant antibody libraries selected specifically for plant nuclear proteins

  • Plant-expressed antibody fragments that function in the same cellular compartments as WRKY23

• Biosensor applications:

  • Conformational sensors using antibodies that detect WRKY23 structural changes

  • FRET-based antibody biosensors to detect WRKY23-DNA or WRKY23-protein interactions

  • Split-antibody complementation systems to visualize WRKY23 activities

• Modified specificity antibodies:

  • Engineering antibodies to distinguish between closely related WRKY family members

  • Developing antibodies specific to different phosphorylated states of WRKY23

  • Creating antibodies that recognize specific WRKY23-DNA complexes

• Therapeutic applications in plant biotechnology:

  • Engineered antibodies that modulate WRKY23 function for stress tolerance

  • Antibody-guided editing systems to modify WRKY23 genomic targets

  • Inducible expression of inhibitory antibodies for temporal control of WRKY23 function

These advances could transform our understanding of how WRKY23 functions in developmental processes and stress responses, particularly in its roles regulating PLT3 and PLT7 transcription and mediating auxin signaling .

What are the emerging methods for multiplexed detection of WRKY23 alongside other transcription factors in plant developmental studies?

Emerging multiplexed detection methods enable simultaneous analysis of WRKY23 with other transcription factors:

• Multiplexed immunofluorescence techniques:

  • Cyclic immunofluorescence (CycIF) allowing sequential staining-imaging-stripping cycles

  • Spectral unmixing with antibodies conjugated to spectrally distinct fluorophores

  • DNA-barcoded antibodies allowing highly multiplexed imaging

• Mass cytometry and imaging mass cytometry:

  • Metal-tagged antibodies against WRKY23 and other transcription factors for simultaneous detection

  • Spatial resolution of multiple transcription factors in tissue sections

  • Quantitative analysis of up to 40 proteins simultaneously

• Multiplex proximity ligation assays:

  • Detection of multiple protein-protein interactions involving WRKY23

  • Visualization of transcription factor complexes with single-molecule resolution

  • Analysis of co-regulatory relationships between WRKY23 and interacting factors

• Spatial transcriptomics with protein detection:

  • Combined analysis of WRKY23 protein localization with target gene expression

  • Integration of antibody-based protein detection with in situ RNA sequencing

  • Correlation of transcription factor binding with chromatin accessibility

• Microfluidic antibody arrays:

  • Single-cell protein analysis of multiple transcription factors

  • Temporal profiling of transcription factor dynamics

  • Correlation of protein levels with cell fate decisions

These approaches would be particularly valuable for understanding how WRKY23 functions within transcriptional networks involving ARF7, ARF19, and PLT family transcription factors during development . For example, multiplexed detection could reveal how WRKY23 coordinates with these factors during auxin-induced callus formation and regeneration processes.

How can computational modeling integrate WRKY23 antibody-based experimental data to predict plant developmental outcomes?

Computational modeling can leverage WRKY23 antibody-based experimental data to predict developmental outcomes through several approaches:

• Quantitative spatiotemporal models:

  • Incorporate antibody-derived WRKY23 concentration data into reaction-diffusion models

  • Model how WRKY23 gradients influence cell fate decisions in meristems

  • Predict developmental outcomes based on perturbations to WRKY23 levels

• Gene regulatory network (GRN) reconstruction:

  • Integrate ChIP-seq data from WRKY23 antibodies with transcriptomic data

  • Build predictive models of downstream gene expression patterns

  • Simulate developmental trajectories based on network perturbations

• Protein-protein interaction networks:

  • Use antibody-based interactome data to build WRKY23 interaction maps

  • Model information flow through signaling networks involving WRKY23

  • Predict phenotypic consequences of disrupting specific interactions

• Multi-scale modeling approaches:

  • Link molecular-level WRKY23 binding data to cellular behaviors

  • Scale up to tissue-level morphogenesis predictions

  • Create virtual plant models incorporating WRKY23 regulatory functions

• Machine learning integration:

  • Train neural networks on antibody-derived WRKY23 distribution patterns

  • Develop predictive algorithms for developmental outcomes

  • Create digital twins of plant developmental systems